本頁面由Tiger Trade Technology Pte. Ltd.提供服務

CG Oncology Inc.

78.23
-1.5800-1.98%
盤後78.230.00000.00%19:30 EDT
成交量:116.26萬
成交額:9,122.33萬
市值:69.34億
市盈率:-28.72
高:79.89
開:79.44
低:77.51
收:79.81
52周最高:80.97
52周最低:25.25
股本:8,864.04萬
流通股本:6,473.22萬
量比:1.56
換手率:1.80%
股息:- -
股息率:- -
每股收益(TTM):-2.7235
每股收益(LYR):-2.0826
淨資產收益率:-26.41%
總資產收益率:-17.67%
市淨率:6.74
市盈率(LYR):-37.56

資料載入中...

2026/08/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/13

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/06

重要事件披露

Form 8-K - Current report
2026/08/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/28

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities